ArchiMed has invested in plasmid DNA and protein therapeutics developer Xpress Biologics, with the intention of implementing a tenfold production capacity increase for the company.
Laboratory and imaging diagnostics service is valued at more than EUR 5bn
IK expanded its UK operations to include a local small-cap team headed by partner Tom Salmon in 2020
Asset manager nets a 10.7% IRR on the investment in its listed peer
Romanian cybersecurity company appoints JP Morgan and Morgan Stanley for a dual-track process